[The influence of intrathecal NMDA receptor antagonist on the isoflurane MAC and on the motor function]

M Yamazaki1

  • 1Department of Anesthesiology, Tsuboi Hospital, Koriyama.

Masui. the Japanese Journal of Anesthesiology
|January 1, 1996
PubMed

Insights

N-methyl-D-aspartate (NMDA) receptor antagonists administered intrathecally reduced isoflurane MAC in rats. NMDA reversed this effect, though motor dysfunction occurred at high antagonist doses.

Area of Science:

  • Neuroscience
  • Anesthesiology
  • Pharmacology

Background:

  • The role of N-methyl-D-aspartate (NMDA) receptors in spinal cord function is not fully understood.
  • NMDA receptors are implicated in pain modulation and synaptic plasticity.
  • Understanding their role in anesthesia is crucial for optimizing anesthetic protocols.

Purpose of the Study:

  • To investigate the effect of intrathecal NMDA receptor antagonists on isoflurane minimum alveolar anesthetic concentration (MAC) in rats.
  • To assess the impact of these antagonists on locomotor function.
  • To explore the potential involvement of spinal NMDA receptors in isoflurane MAC determination.

Main Methods:

  • Wistar rats received intrathecal catheters for drug administration.
  • Isoflurane MAC was determined after administration of competitive (AP7) and non-competitive (MK801) NMDA receptor antagonists, NMDA, or saline.
  • Locomotor function was evaluated using a standardized test.

Main Results:

  • Intrathecal AP7 and MK801 significantly decreased isoflurane MAC in a dose-dependent manner.
  • Intrathecal NMDA administration partially reversed the MAC-lowering effects of the antagonists.
  • High doses of NMDA antagonists induced locomotor dysfunction, while lower doses reduced MAC without motor impairment.

Conclusions:

  • NMDA receptor antagonists influence isoflurane MAC, suggesting a role for spinal NMDA receptors in anesthetic requirements.
  • The observed motor dysfunction at high antagonist doses indicates a threshold effect.
  • Further research is warranted to elucidate the precise mechanisms underlying NMDA receptor modulation of anesthetic depth.

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.